Tissue-Specific Differences in The Induction of Type 2 Immunity are Controlled by Specialized Dendritic Cell Subsets
• Professor for Dermatological Immunotherapy, University Medical Center of the Johannes
Gutenberg-University Mainz
• Member of the Research Center for Immunotherapy, the Center for Healthy Ageing and the Institute
for Quantitative & Computational Bioscievvnces
Cellular Senescence in Cornelia de Lange Syndrome :
A Pharmacological Target?
• Research director at Inserm
• Team leader and senior researcher
Cancer Immunosuppression and How to Conquer it
• John M. and Mary Jo Boler Collegiate Associate Professor, University of Notre Dame
• Full Member of Tumor Microenvironment and Metastasis Program, Indiana University
Simon Comprehensive Cancer Center
30 Years in PI 3-kinase Research: Lessons Learned
and Looking to the Future
• Professor of Cell Signalling at the UCL Cancer Institute
• Elected member of EMBO and the UK Academy of Medical Sciences
Stressing Out Therapy Resistant Cancers
• Baylor College of Medicine Associate Professor
• Cullen Duncan McAshan Endowed Chair in Cancer Research